"My name is Nancy Gurish and currently I am the editor of an internet magazine titled Your Health And Tech Friend. I had been told by my general practitioner to 'wait and see' about a few things for myself and my family members. This page is dedicated to the concept of 'wait and see' as an acceptable, practical medical opinion. My feelings, after studying, for the past maybe six years; I've studied a great deal of topics on the internet, with regard to health issues. Personal stories and modes of 'prevention' of diseases and disorders. I am now of the firm opinion that 'come back in a year' is not acceptable. It is downright wrong in many if not all cases. I have taped a video which I will include on this page. I'll be updating this page to add more stories about the 'wait and see' approach; and others' input on this subject. Nancy Gurish, Editor, Editor, Your Health And Tech Friend Magazine
documented for nearly 2,000 years, very little
solid science exists to validate the beneficial
effects on human health. Cells communicate
with one another through a complex series
of signals to achieve an end result, normally
the creation of a protein or the completion
of an enzymatic reaction. When this chain
is broken as a result of poor diet or lifestyle
choices that affect metabolic homeostasis,
diseases such as cancer are allowed to develop
and manifest in tissues throughout the body."
...this text below...
"...Researchers found that when the chain is
broken, tumor growth is halted and metastatic
growth stops. They found that a derivative
of milk thistle called silibinin was able
to inhibit the upstream signals that lead
to the expression of COX2 and iNOS and help
prevent lung cancer." continue reading below...
"...Over the course of 2000 years, milk
thistle (Silybum marianum) has earned a beneficial reputation in matters
relating to the liver, kidneys and gall bladder.
Its most well known compound, the flavonoid
silymarin derived from the seed of the plant,
has both antioxidant and anti-inflammatory
properties and has been the subject of many
animal and human studies that have yielded
mixed results. The most recent study of note
focused on silibinin, another component of
milk thistle, and its effect on cancer cells
in mice.
In a study published in the journal Molecular Carcinogenesis,researchers at the University of Colorado
Cancer Center treated lung cancer cells in
mice with silibinin and found the compound
inhibited tumorigenesis in part by targeting
the tumor’s microenvironment. " see this below...
".... "This relatively nontoxic
substance - a derivative of milk thistle,
called silibinin - was able to inhibit the
upstream signals that lead to the expression
of COX2 and iNOS," said Tyagi.
